Serodiagnosis of lyme disease: Accuracy of a two-step approach using a flagella-based ELISA and immunoblotting

Journal of Infectious Diseases

Volumn 174, Issue 2, 1996, Pages 346-353

  Johnson, Barbara J B ^a   Robbins, Kenneth E ^a,b   Bailey, Raymond E ^a   Cao, Bo Liang ^a,c   Sviat, Steven L ^a   Craven, Robert B ^a   Mayer, Leonard W ^a,b   Dennis, David T ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; BLOOD DONOR; BORRELIA BURGDORFERI; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; FLAGELLUM; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LYME DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SERODIAGNOSIS; SINGLE BLIND PROCEDURE; SKIN BIOPSY;

EID: 0029894761     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.2.346     Document Type: Article

References (14)

1. Barbour AG. Laboratory aspects of Lyme borreliosis. Clin Microbiol Rev 1988;1:399-414.
2. Steere AC. Lyme disease. N Engl J Med 1989;321:586-96.
3. Spach DH, Liles WC, Campbell GL, Quick RE, Anderson DE Jr, Fritsche TR. Tick-borne diseases in the United States. N Engl J Med 1993;329:936-47.
4. Centers for Disease Control and Prevention. Lyme disease surveillance - United States, 1994. MMWR Morb Mortal Wkly Rep 1995;44:459-62.
5. Coyle BS, Strickland GT, Liang YY, Pena C, McCarter R, Israel E. The public health impact of Lyme disease in Maryland. J Infect Dis 1996;174:1260-2.
6. Sigal LH. Lyme disease: testing and treatment. Who should be tested and treated for Lyme disease and how? Rheum Dis Clin North Am 1993;19:79-93.
7. Barbour AG, Burgdorfer W, Grunwaldt E, Steere AC. Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J Clin Invest 1983;72:504-15.
8. Craft JE, Fischer DK, Shimamoto GT, Steere AC. Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. J Clin Invest 1986;78:934-9.
9. Grodzicki RL, Steere AC. Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease. J Infect Dis 1988;157:790-7.
10. Hansen K, Hinderesson P, Pederson NS. Measurement of antibodies to the Borrelia burgdorferi flagellum improves serodiagnosis in Lyme disease. J Clin Microbiol 1988;26:338-46.
11. Hansen K, Åsbrink E. Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme-linked immunosorbent assay. J Clin Microbiol 1989;27:545-51.
12. Hansen K, Pii K, Lebech AM. Improved immunoglobulin M serodiagnosis in Lyme borreliosis by using a μ-capture enzyme-linked immunosorbent assay with biotinylated Borrelia burgdorferi flagella. J Clin Microbiol 1991;29:166-73.
13. Karlsson M, Stiemstedt G, Granström M, Åsbrink E, Wretlind B. Comparison of flagellum and sonicate antigens for serological diagnosis of Lyme borreliosis. Eur J Clin Microbiol Infect Dis 1990;9:169-77.
14. Hedberg CW, Osterholm MT, MacDonald KL, White KE. An interlaboratory study of antibody to Borrelia burgdorferi. J Infect Dis 1987;155:1325-7.